Neuronetics (STIM) Interest Coverage Ratio (2017 - 2026)
Neuronetics' (STIM) quarterly Interest Coverage Ratio came in at 3.97 in Q1 2026, up 25.25% year-on-year from 3.17 in Q1 2025, and down 24.05% on a QoQ basis from 3.2 in Q4 2025.
Neuronetics (STIM) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Interest Coverage Ratio data on file, last reported at 3.97 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 25.25% year-over-year to 3.97 in Q1 2026; TTM through Mar 2026 was 3.83, a 28.85% increase from a year earlier, with the FY2025 full-year figure at 3.74, down 1348.22% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.97, down from 3.2 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for STIM reached as high as 0.8 in Q2 2025 and fell as low as 7.91 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 4.71 across 5 years, with a median of 4.48 in 2024.
- Across the five-year window, Interest Coverage Ratio slumped 2065.63% in 2022 and surged 84.77% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 4.41 in 2022, then jumped by 39.93% to 2.65 in 2023, then tumbled by 146.31% to 6.53 in 2024, then soared by 50.99% to 3.2 in 2025, then declined by 24.05% to 3.97 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 3.97 in Q1 2026, 3.2 in Q4 2025, and 1.53 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | -3.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.97 |
| Dec 31, 2025 | -3.20 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -0.80 |
| Mar 31, 2025 | -5.31 |
| Dec 31, 2024 | -6.53 |
| Sep 30, 2024 | -4.48 |
| Jun 30, 2024 | -5.22 |
| Mar 31, 2024 | -3.76 |
| Dec 31, 2023 | -2.65 |
| Sep 30, 2023 | -7.49 |
| Jun 30, 2023 | -7.35 |
| Mar 31, 2023 | -7.91 |
| Dec 31, 2022 | -4.41 |
| Sep 30, 2022 | -5.92 |
| Jun 30, 2022 | -7.58 |
| Mar 31, 2022 | -1.97 |
| Dec 31, 2021 | -19.80 |
| Sep 30, 2021 | -1.28 |
| Jun 30, 2021 | -0.35 |